BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
81 hedge funds and large institutions have $660M invested in Audentes Therapeutics, Inc in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 6 closing their positions.
Holders
81
Holders Change
+11
Holders Change %
+15.71%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
24
Reduced
23
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$91.7M |
| 2 |
AG
2
Artal Group
Luxembourg
|
$5.6M |
| 3 |
AC
3
Ascend Capital
Orinda,
California
|
$4.25M |
| 4 |
4
Morgan Stanley
New York
|
$4.22M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$3.11M |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$116M |
| 2 |
2
BlackRock
New York
|
$33.6M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$0 |
| 4 |
DM
4
Deerfield Management
New York
|
$42.7M |
| 5 |
RG
5
Redmile Group
San Francisco,
California
|
$36.1M |
